Bright Health Group, Inc.

NYSE:BHG

16.35 (USD) • At close January 26, 2024
Overview | Financials

Numbers are in millions (except for per share data and ratios) USD.

2025 Q22025 Q12024 Q42024 Q32024 Q22023 Q42023 Q32023 Q22023 Q12022 Q42022 Q32022 Q22022 Q12021 Q42021 Q32021 Q22021 Q12020 Q42020 Q32020 Q22020 Q1
Revenue 209.082215.78776.405232.933225.991292.871269.399297.982756.341551.4251,632.2921,576.6281,835.575962.3341,078.6571,113.84874.558359.778352.12296.856198.566
Cost of Revenue 146.41160.894-59.763246.768247.898330.305226.438245.16688.515519.2911,456.8621,398.1661,580.5962,604.6591,050.943904.63684.57372.186311.319233.18130.615
Gross Profit 62.67254.893136.168-13.835-21.907-37.43442.96152.82267.82632.134175.43178.462254.979-1,642.32527.714209.21189.988-12.40840.80163.67667.951
Gross Profit Ratio 0.30.2541.782-0.059-0.097-0.1280.1590.1770.090.0580.1070.1130.139-1.7070.0260.1880.217-0.0340.1160.2150.342
Reseach & Development Expenses 000000000000000000000
General & Administrative Expenses 00129.8900065.9463.95108.869-173.456221.904213.805239.588248.644161.545119.68296.48965.77956.33346.87142.766
Selling & Marketing Expenses 00-0.8880000.2580.6320.344-167.11877.72179.9391.807104.11969.44363.98850.20557.88615.94114.4748.64
SG&A 00130.77800066.19864.58129.213-340.574299.625293.735331.395352.763230.988183.67146.694123.66572.27461.34551.406
Other Expenses 194.825213.126400.462250.275263.54338.806732.174321.39621.002536.70711.724132.814100.5641,782.3311.22684.58566.12727.75827.78329.56723.825
Operating Expenses 194.825213.126531.24250.275263.54338.80699.0774.951150.215196.133311.349426.549431.9591,782.331323.995268.255212.821151.423100.05790.91275.231
Operating Income 14.2572.661446.958-26.007-39.259-62.827-462.775-23.414-82.389-163.999-135.919-248.087-176.98-819.997-296.281-59.045-22.833-163.831-59.256-27.236-7.28
Operating Income Ratio 0.0680.0125.85-0.112-0.174-0.215-1.718-0.079-0.109-0.297-0.083-0.157-0.096-0.852-0.275-0.053-0.026-0.455-0.168-0.092-0.037
Total Other Income Expenses Net 0030.0922.793-0.187-2.073-426.581-0.8921.259-115.483-121.679-179.7-80.569-856.903-0.368-4.142-0.546-3.8000
Income Before Tax 6.817-1.327477.05-23.214-39.446-61.237-482.69-32.584-93.533-192.462-257.598-248.426-177.389-821.671-296.649-63.187-23.379-163.831-59.256-27.236-7.28
Income Before Tax Ratio 0.033-0.0066.244-0.1-0.175-0.209-1.792-0.109-0.124-0.349-0.158-0.158-0.097-0.854-0.275-0.057-0.027-0.455-0.168-0.092-0.037
Income Tax Expense -0.0210.1115.2842.793-0.1871.59-3.385-0.8921.259-4.2281.7632.9043.24-8.2960.073-19.4641.1660.0010-9.1620
Net Income -23.501-24.875996.63-70.475-71.39-242.332-633.895-112.832-94.792-188.234-259.361-251.33-180.629-813.375-300.664-44.518-25.162-163.832-59.256-18.074-7.28
Net Income Ratio -0.112-0.11513.044-0.303-0.316-0.827-2.353-0.379-0.125-0.341-0.159-0.159-0.098-0.845-0.279-0.04-0.029-0.455-0.168-0.061-0.037
EPS -2.62-2.9101.46-8.51-8.65-30.47-79.47-14.17-12.01-23.97-32.95-31.96-22.9827.65-38.16-22.13-14.36-95.67-34.77-10.65-4.25
EPS Diluted -2.62-2.9101.46-8.51-8.65-30.47-79.47-14.17-12.01-23.97-32.95-31.96-22.9827.65-38.16-22.13-14.36-95.67-34.77-10.65-4.25
EBITDA -13.089-14.568797.662-58.765-63.489-225.512-51.986-15.994-72.498-153.597-122.013-234.86-163.155-810.494-280.85-51.85-18.252-161.092-56.578-25.151-6.493
EBITDA Ratio -0.063-0.06810.44-0.252-0.281-0.77-0.193-0.054-0.096-0.279-0.075-0.149-0.089-0.842-0.26-0.047-0.021-0.448-0.161-0.085-0.033